GS-441524 CAS 1191237-69-0

remdesivir (GS-5734) is a novel nucleoside analogues antiviral developed by GileadScience Company (GileadScience), an RNA-dependent RNA polymeric Chemicalbook enzyme (RdRp) inhibitor. It can play an antiviral role by inhibiting the synthesis of viral nucleic acid. Redesivir is not currently on the market in the world, phase I and Phase II clinical trials for the indication of anti-Ebola virus (filovirus), phase III trials have not yet started.

GS-441524 is a small molecule, riboside triphosphate competitive inhibitor, that has demonstrated strong antiviral activity against many RNA viruses. It can inhibit the replication of several different types of RNA viruses, such as zoonotic severe acute respiratory syndrome (SARS) coronavirus, Middle East Respiratory syndrome virus, Ebola virus, Lassa fever virus, Junin virus, and respiratory syncytial virus, while having low cytotoxicity in a wide range of cell lines.

我們擁有許多深度合作的優質工廠，可以為您提供高品質的產品和有競爭力的價格。並且我們還可以對大量採購給予折扣。確認付款後，交貨時間約 3-20 天。

1.你們是工廠還是貿易公司？
我們是一家工貿一體化的公司，提供一站式服務。

2.你們提供樣品嗎？是免費的還是額外的？
免費樣品。

3.你們有與品質控制相關的證書嗎？
ISO 9001:2008 認證確保品質。

4.我應該提供什麼才能獲得報價？
請告知我們您需要的產品類型、訂購數量、地址及具體要求，我們將及時報價供您參考。

5.您喜歡哪種付款方式？接受什麼樣的條款？
接受的交貨條件：FOB、CFR、CIF、EXW；
接受的付款貨幣：美元；
接受的付款方式：T/T、西聯匯款；貝寶，貿易保證。
使用語言：英語。